N-Nitroso Oxetacaine Stage D | N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.N-Nitroso Oxetacaine Stage D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines .N-Nitroso Oxetacaine Stage D is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Oxetacaine Stage D CAS NO: NA Chemically represented as N-methyl-N-(2-methyl-1-phenylpropan-2-yl)nitrous amide.Synchemia is the leading manufacturing and exporter of N-Nitroso Oxetacaine Stage D .We supply N-Nitroso Oxetacaine Stage D with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142771 |
| CAS No | NA |
| Mol.F. | C14H10BrClN203 |
| Mol.Wt. | 369.60 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142772 |
| CAS No | NA |
| Mol.F. | C14H10Cl2N2O4 |
| Mol.Wt. | 341.14 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142773 |
| CAS No | NA |
| Mol.F. | C21H16Cl2N2O3 |
| Mol.Wt. | 415.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142774 |
| CAS No | NA |
| Mol.F. | C18H18Cl2N2O4 |
| Mol.Wt. | 397.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142775 |
| CAS No | NA |
| Mol.F. | C20H18Cl2N2O9 |
| Mol.Wt. | 501.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142776 |
| CAS No | NA |
| Mol.F. | C23H22Cl2N2O9 |
| Mol.Wt. | 541.33 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142777 |
| CAS No | NA |
| Mol.F. | C28H19Cl4N3O5 |
| Mol.Wt. | 619.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142778 |
| CAS No | NA |
| Mol.F. | C26H34Cl2N2O3 |
| Mol.Wt. | 493.47g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142779 |
| CAS No | NA |
| Mol.F. | C24H28Cl2N2O3 |
| Mol.Wt. | 463.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142780 |
| CAS No | NA |
| Mol.F. | C32H42Cl2N2O4 |
| Mol.Wt. | 589.60 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142781 |
| CAS No | NA |
| Mol.F. | C35H50Cl2N2O4 |
| Mol.Wt. | 633.70 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142782 |
| CAS No | NA |
| Mol.F. | C14H9ClN2O3 |
| Mol.Wt. | 288.69 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142783 |
| CAS No | NA |
| Mol.F. | C14H10N2O3 |
| Mol.Wt. | 254.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142784 |
| CAS No | NA |
| Mol.F. | C17H18ClN3O2 |
| Mol.Wt. | 331.8 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142785 |
| CAS No | NA |
| Mol.F. | C17H18ClN3O2 |
| Mol.Wt. | 331.8 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142786 |
| CAS No | NA |
| Mol.F. | C17H19N3O2 |
| Mol.Wt. | 297.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |